Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

VC funding in India startups soars to $6.3 billion during January-July 2024 despite global caution, finds GlobalData

India’s startup ecosystem saw a significant surge in venture capital (VC) funding during January-July 2024, with a total of 672 deals raising $6.3 billion. This represents a massive 42.1% year-on-year (YoY) increase in funding value, despite a modest 1.2% rise in deal volume. The spike in funding highlights investor confidence in India’s promising startups, even […]
Read more

AI and cybersecurity take center stage in Q2 2024 company filings, reveals GlobalData

Technology, travel and tourism, and insurance business sentiment improves Packaging and retail hit by shifting preferences and rising costs Israel, Indonesia, the UK, and the US witness sentiment growth Global business sentiment witnessed a marginal improvement of 0.2% year-over-year (YoY) during the second quarter (Q2) of 2024. While technology, travel and tourism, and insurance sectors […]
Read more

rVSV-ZEBOV vaccine first real-world data support prophylactic use for future Ebola outbreaks, says GlobalData

The rVSV-ZEBOV vaccine has demonstrated real-world effectiveness of approximately 84% against Ebola virus disease, revealed a recent study carried out by researchers in Europe and the Democratic Republic of the Congo (DRC). This retrospective, test-negative study, which analyzed 618 individuals during the 2018-2020 Ebola virus epidemic in the DRC, supports the prophylactic use of rVSV-ZEBOV […]
Read more

Rising ADHD diagnoses in 7MM linked to standardized screening tools and guidelines, says GlobalData

The increase in attention-deficit/hyperactivity disorder (ADHD) diagnoses across the seven major markets (7MM*) is closely tied to the adoption of standardized screening tools and updated clinical guidelines. These developments, particularly in the US, have led to more accurate identification of ADHD cases, especially among adults, helping to address the disorder’s significant socioeconomic and mental health […]
Read more

Top 50 APAC listed firms report 0.8% revenue dip amid oil and gas struggles, China’s slow recovery, reveals GlobalData

China dominates the list with 26 companies BYD, Dai-ichi Life Holdings, and Toyota Motor gain over 20% in revenue Financial services sector tops the list with 13 companies The top 50 listed companies in the Asia-Pacific (APAC) region faced a slight 0.8% year-on-year (YoY) dip in aggregate revenue, totaling $6.9 trillion, in 2023. The downturn […]
Read more

China pharma firms eye stronghold in therapeutic cancer vaccines market, says GlobalData

Cancer vaccines represent a burgeoning field in oncology, with the potential to revolutionize cancer treatment. Earlier, approved cancer vaccines were prophylactic against cancer-causing viruses. However, recent advancements have shifted towards developing therapeutic cancer vaccines, which focus on identifying tumor-specific antigens to create innovative cancer immunotherapies. In this context, Chinese companies are actively positioning themselves to […]
Read more

US respiratory test market faces uncertainty as flu season approaches amid shift to complex assays, finds GlobalData

The US respiratory test market remains volatile post-COVID-19 pandemic, with fluctuating demand influenced by seasonal factors and evolving testing preferences. As flu season approaches, the market faces uncertainty, particularly due to the shift toward more complex and higher-priced testing assays. This transition could lead to significant variations in sales volumes and revenue, highlighting the market’s […]
Read more

Ransomware surge in 2024 demands coordinated global response, says GlobalData

Amid intensifying geopolitical tensions, ransomware attacks in 2024 are set to reach record levels, escalating the risks faced by companies worldwide. There is a shift toward more sophisticated extortion tactics, emphasizing the urgent need for coordinated global action and robust incident response strategies as organizations confront increasingly aggressive and persistent cyber threats, says GlobalData, a […]
Read more

Mpox sparks surge in influencer discussions on X following WHO global health emergency declaration, reveals GlobalData

The re-emergence of monkeypox (mpox) has ignited critical discussions among the global health experts on social media platform X in the second week of August 2024, following the World Health Organization’s (WHO) classification of mpox as Public Health Emergency of International Concern. As the clade I variant, widespread in Africa, poses significant risks including severe […]
Read more

Gilead’s Livdelzi wins FDA approval, challenges Ocaliva dominance in primary biliary cholangitis market, says GlobalData

Gilead Sciences has recently announced the US FDA’s approval of seladelpar, its PPAR-δ agonist, under the brand name Livdelzi, for primary biliary cholangitis (PBC). This major turnaround for seladelpar, once a failed non-alcoholic steatohepatitis (NASH) asset, follows Gilead’s acquisition of the asset’s developer, Cymabay Therapeutics, earlier this year. The approval could present a major challenge […]
Read more

Disruptive technologies set to revolutionize consumer goods value chain by 2035, reveals GlobalData

Disruptive technologies are set to revolutionize the consumer goods value chain from automated farms to robot-run shops over the next 10 years. As precision agriculture, plant-based proteins, and AI-driven retail evolve, industries will undergo profound transformations. These innovations, driven by the need for efficiency and sustainability, promise to reshape how we produce, consume, and interact […]
Read more

Stereotaxis GenesisX EU nod marks major shift in robotic-assisted surgery market, says GlobalData

The EU clearance of Stereotaxis’ endovascular robotic system “GenesisX” marks a significant advancement in the rapidly growing field of robotic-assisted surgery. As the global market for these systems is set to surge, driven by the need for precision in minimally invasive procedures, this highlights the industry’s shift towards innovative technologies that improve surgical outcomes and […]
Read more

Barclays leads Wimbledon sponsorship surge as prize money and media value hit new highs, reveals GlobalData

The 2024 Wimbledon Championships saw record-breaking sponsorship and prize money, reflecting the event’s growing financial clout. Barclays’ significant $118.65 million deal highlighted the tournament’s evolving commercial landscape, while British Broadcasting Corp’s (BBC) media coverage underscored shifting viewer dynamics. Despite lower viewership due to competition with the UEFA final, Wimbledon’s commitment to equal prize money continues […]
Read more

Nuclear fusion startups usher in next era of sustainable energy innovation, says GlobalData

Nuclear fusion technology is rapidly advancing, bringing us closer to a sustainable, limitless energy source. Startups are pioneering innovations like cold fusion, superconducting magnets, laser-ignited capsules, and projectile fusion, addressing the critical challenges of sustained reactions and scalable reactor designs. These breakthroughs mark a transformative moment in energy research, potentially revolutionizing global power generation and […]
Read more

Telcos should adopt pragmatic approach to verticalizing B2B sales by leveraging core horizontal strengths, says GlobalData

Most telecom companies operating in the enterprise market often alternate between verticalized and horizontal sales strategies. While verticalization aims to deepen sector-specific partnerships and boost B2B sales, it often leads to unrealistic expectations and strategic recalibration. To achieve sustainable growth, telcos should adopt a pragmatic approach, focusing on their core horizontal strengths—such as connectivity and […]
Read more
1 … 50 51 52 53 54 … 206